차이

문서의 선택한 두 판 사이의 차이를 보여줍니다.

차이 보기로 링크

양쪽 이전 판이전 판
다음 판
이전 판
med:drugs_in_pregnancy_and_breastfeeding [2016/11/23 08:11] V_Lmed:drugs_in_pregnancy_and_breastfeeding [2017/01/31 03:55] (현재) V_L
줄 4: 줄 4:
 [[med:breastfeeding|모유수유]] 독성 검색 엔진 http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT [[med:breastfeeding|모유수유]] 독성 검색 엔진 http://toxnet.nlm.nih.gov/cgi-bin/sis/htmlgen?LACT
  
-|CATEGORY|INTERPRETATION| +http://www.druginfo.co.kr/p/pcp-search/ 
-|A|Adequate, well-controlled studies in pregnant women have not shown an increased risk of fetal abnormalities to the fetus in any trimester of pregnancy.+ 
-|B|Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant womenOR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.+
-|C|Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.| +
-|D|Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.| +
-|X|Adequate well-controlled or observational studies in animals or pregnant women have demonstrated positive evidence of fetal abnormalities or risks.| +
-The use of the product is contraindicated in women who are or may become pregnant.| +
- +
  
   * 출처: [[http://www.perinatology.com/Archive/FDA%20CAT.htm|]]   * 출처: [[http://www.perinatology.com/Archive/FDA%20CAT.htm|]]
  
 +[[Pregnancy_drug]]